Alnylam to appeal COVID-19 vaccine patent ruling in Moderna case
Fierce Pharma
AUGUST 28, 2023
As Alnylam persists in its COVID-19 patent litigation, the RNAi specialist has been dealt a blow in one of its lawsuits against Moderna. | As Alnylam persists in its COVID-19 patent litigation, the RNAi specialist has been dealt a blow in one of its lawsuits against Moderna.
203 
Let's personalize your content